FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
Amid escalating diplomatic tensions, Russia and Poland engage in a tit-for-tat closure of consulates, underscoring the worsening relations between the two countries.
UK and France announce new migrant returns deal, but its limited scale draws criticism amid ongoing Channel crossings.
FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
Amid escalating diplomatic tensions, Russia and Poland engage in a tit-for-tat closure of consulates, underscoring the worsening relations between the two countries.
UK and France announce new migrant returns deal, but its limited scale draws criticism amid ongoing Channel crossings.